FREMONT, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) is set to elevate its presence at this year’s premier clinical industry events across the globe. Continuing ...
Cytek Biosciences, Inc. is highlighting its Full Spectrum Profiling™ (FSP®) technology at the upcoming CYTO 2025 and IMMUNOLOGY2025 conferences to promote advancements in cell analysis. This ...
FREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- With cancer research and diagnostics driving the need for deeper, faster cellular insights, spectral flow cytometry leader Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) is set to elevate its presence at this year’s premier clinical industry events across the globe. Continuing ...
FREMONT, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- In a move that underscores its dedication to shaping the future of cell analysis, Cytek Biosciences, Inc. (CTKB) (Nasdaq: CTKB) today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results